Frontiers in Hematology

Review

Published on 28 Mar 2024

Blood pharming: exploring the progress and hurdles in producing in-vitro red blood cells for therapeutic applications

in Hematopoiesis and Stem Cells

Hammad Hassan
Sheerien Rajput

Frontiers in Hematology

doi 10.3389/frhem.2024.1373408

2,614 views

Review

Published on 26 Mar 2024

Asymmetric cell division of hematopoietic stem cells: recent advances, emerging concepts, and future perspectives

in Hematopoiesis and Stem Cells

Jessica Nunes
Dirk Loeffler

Frontiers in Hematology

doi 10.3389/frhem.2024.1373554

2,910 views
2 citations

Case Report

Published on 21 Mar 2024

Case report: Donor lymphocyte infusion and blinatumomab as treatment for acute lymphoblastic leukemia relapse after allogeneic hematopoietic stem cell transplantation

in Blood Cancer

Flavia Antonucci
Serena Marotta
Maria Celentano
Mariangela Pedata
Cira Riccardi
Cristina Luise
Angela Carobene
Simona Maria Muggianu
Assunta Viola
Mafalda Caputo

Frontiers in Hematology

doi 10.3389/frhem.2024.1345884

890 views

Opinion

Published on 18 Mar 2024

The impact of NETosis on hematological malignancies as a promising therapeutic target

in Blood Cancer

Duygu Aydemir

Frontiers in Hematology

doi 10.3389/frhem.2024.1377806

1,048 views
1 citation

Review

Published on 08 Mar 2024

Management of secondary immunodeficiency in hematological malignancies: a Delphi consensus from the Middle East

in Immunobiology and Immunotherapy

Maria Dimou
Mohamed Abuzakouk
Mona Al Ahmad
Khalil Al Farsi
Ahmad Alhuraiji
Fayhan Al Roqi
Ahmed Alsaeed
Mohsen Alzahrani
Ali Bazarbachi
Honar Cherif

Frontiers in Hematology

doi 10.3389/frhem.2024.1347708

2,125 views
1 citation

Case Report

Published on 06 Mar 2024

Case report: Childhood erythrocytosis due to hypermanganesemia caused by homozygous SLC30A10 mutation

in Red Cells, Iron and Erythropoiesis

Tiziana Coppola
Hannah Hughes
Paul T. Finch
Joshua A. Hess
Steve Wu
Carlos E. Prada
Alexander G. Miethke
Wenying Zhang
Theodosia A. Kalfa

Frontiers in Hematology

doi 10.3389/frhem.2024.1331485

959 views
1 citation

Case Report

Published on 06 Mar 2024

Case report: A patient with ALK-positive large B-cell lymphoma benefited from myeloma-like treatment combined with the ALK inhibitor lorlatinib

in Blood Cancer

Dan Liu
Lijie Xing
Hui Wang
Ping Li
Haichen Wei

Frontiers in Hematology

doi 10.3389/frhem.2024.1334577

1,047 views
1 citation

Review

Published on 01 Mar 2024

Exploring the intricate cross-talk between clonal expansion and the bone marrow niche

in Hematopoiesis and Stem Cells

Steven Ngo
Despoina Papazoglou
Hector Huerga Encabo
Dominique Bonnet

Frontiers in Hematology

doi 10.3389/frhem.2024.1334807

1,798 views
1 citation

Review

Published on 19 Feb 2024

Hypersialylation and multiple myeloma

in Blood Cancer

Michael O’Dwyer
Siobhan Glavey
Roisin McAvera
Alessandro Natoni
Aideen E. Ryan

Frontiers in Hematology

doi 10.3389/frhem.2024.1360149

4,184 views
1 citation

Review

Published on 15 Feb 2024

Research and clinical updates on IRAK4 and its roles in inflammation and malignancy: themes and highlights from the 1st symposium on IRAK4 in cancer

in Blood Cancer

Guillermo Garcia-Manero
Uwe Platzbecker
Kian-Huat Lim
Grzegorz Nowakowski
Omar Abdel-Wahab
Hagop Kantarjian
Amit Verma
Daniel T. Starczynowski

Frontiers in Hematology

doi 10.3389/frhem.2024.1339870

4,470 views
5 citations

Original Research

Published on 05 Feb 2024

Predicting factors of survival rates among alpha- and beta-thalassemia patients: a retrospective 10-year data analysis

in Red Cells, Iron and Erythropoiesis

Kunapa Iam-arunthai
Tawatchai Suwanban
Pravinwan Thungthong
Supat Chamnanchanunt
Suthat Fucharoen

Frontiers in Hematology

doi 10.3389/frhem.2024.1339026

3,551 views

Review

Published on 02 Feb 2024

How artificial intelligence revolutionizes the world of multiple myeloma

in Blood Cancer

Martha Romero
Adrián Mosquera Orgueira
Mateo Mejía Saldarriaga

Frontiers in Hematology

doi 10.3389/frhem.2024.1331109

3,258 views
3 citations

Brief Research Report

Published on 25 Jan 2024

Concanavalin A staining: a potential biomarker to predict cytarabine sensitivity in acute myeloid leukemia

in Blood Cancer

Tao Zhang
Glenn Marsman
Diego A. Pereira-Martins
Manfred Wuhrer
Gerwin A. Huls
Valerie R. Wiersma

Frontiers in Hematology

doi 10.3389/frhem.2023.1302328

1,443 views
1 citation

Review

Published on 25 Jan 2024

De novo drug design through artificial intelligence: an introduction

in Blood Cancer

Davide Crucitti
Carlos Pérez Míguez
José Ángel Díaz Arias
Diego Beltrán Fernandez Prada
Adrián Mosquera Orgueira

Frontiers in Hematology

doi 10.3389/frhem.2024.1305741

7,183 views
7 citations

Original Research

Published on 19 Jan 2024

Generation, characterization, and use of EKLF(Klf1)/CRE knock-in mice for cell-restricted analyses

in Red Cells, Iron and Erythropoiesis

Li Xue
Kaustav Mukherjee
Kevin A. Kelley
James J. Bieker

Frontiers in Hematology

doi 10.3389/frhem.2023.1292589

1,190 views

Mini Review

Published on 11 Jan 2024

Mini review of metabolism in leukaemia: from complexity to the clinic

in Hematopoiesis and Stem Cells

Kevin M. Rattigan

Frontiers in Hematology

doi 10.3389/frhem.2023.1353994

842 views